Proteome Sciences (LSE:PRM) Gross Margin % : 9.25% (As of Jun. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Proteome Sciences Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Proteome Sciences's Gross Profit for the six months ended in Jun. 2024 was £0.21 Mil. Proteome Sciences's Revenue for the six months ended in Jun. 2024 was £2.22 Mil. Therefore, Proteome Sciences's Gross Margin % for the quarter that ended in Jun. 2024 was 9.25%.

Warning Sign:

Proteome Sciences PLC gross margin has been in long-term decline. The average rate of decline per year is -8.7%.

The historical rank and industry rank for Proteome Sciences's Gross Margin % or its related term are showing as below:

LSE:PRM' s Gross Margin % Range Over the Past 10 Years
Min: 2.11 Med: 59.61 Max: 65.09
Current: 2.11

During the past 13 years, the highest Gross Margin % of Proteome Sciences was 65.09%. The lowest was 2.11%. And the median was 59.61%.

LSE:PRM's Gross Margin % is ranked worse than
95.57% of 203 companies
in the Medical Diagnostics & Research industry
Industry Median: 46.79 vs LSE:PRM: 2.11

Proteome Sciences had a gross margin of 9.25% for the quarter that ended in Jun. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Proteome Sciences was -8.70% per year.

Proteome Sciences Gross Margin % Historical Data

The historical data trend for Proteome Sciences's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteome Sciences Gross Margin % Chart

Proteome Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Margin %

Get a 7-Day Free Trial

63.45

54.39

57.71

61.27

32.76

Proteome Sciences Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Gross Margin %	Get a 7-Day Free Trial															55.57	65.35	55.05	-6.60	9.25

Competitive Comparison of Proteome Sciences's Gross Margin %

For the Diagnostics & Research subindustry, Proteome Sciences's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Proteome Sciences's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Proteome Sciences's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Proteome Sciences's Gross Margin % falls into.

Proteome Sciences Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Proteome Sciences's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	1.6	/	5.028
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(5.028 - 3.381)	/	5.028
	=	32.76 %

Proteome Sciences's Gross Margin for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )	=	Gross Profit (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	0.2	/	2.217
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(2.217 - 2.012)	/	2.217
	=	9.25 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Proteome Sciences (LSE:PRM) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Proteome Sciences had a gross margin of 9.25% for the quarter that ended in Jun. 2024 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Proteome Sciences Gross Margin % Related Terms

Thank you for viewing the detailed overview of Proteome Sciences's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Proteome Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Proteome Sciences PLC (LSE:PRM) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

PMSNF:USA PRM.GB:UK PI2:Germany

Address

Downside Bridge Road, Coveham House, Cobham, Surrey, GBR, KT11 3EP

Website

https://www.proteomics.com

Proteome Sciences PLC is protein biomarker research and development. The company uses high sensitivity proprietary techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product. Geographically, it has a presence in the United States, the United Kingdom, and the European Union.